Suhong Tong
Concepts (370)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cardiopulmonary Bypass | 5 | 2019 | 203 | 0.700 |
Why?
| Alkaline Phosphatase | 5 | 2019 | 157 | 0.580 |
Why?
| Hyperglycinemia, Nonketotic | 3 | 2022 | 46 | 0.500 |
Why?
| Infant | 27 | 2024 | 8293 | 0.410 |
Why?
| Smoking Prevention | 2 | 2010 | 150 | 0.400 |
Why?
| Cardiac Surgical Procedures | 4 | 2019 | 461 | 0.380 |
Why?
| Smoking Cessation | 2 | 2010 | 360 | 0.330 |
Why?
| Postoperative Complications | 7 | 2019 | 2235 | 0.320 |
Why?
| Community-Institutional Relations | 1 | 2008 | 91 | 0.320 |
Why?
| Infant, Newborn | 17 | 2022 | 5255 | 0.310 |
Why?
| Retrospective Studies | 23 | 2023 | 12978 | 0.290 |
Why?
| Down Syndrome | 3 | 2017 | 356 | 0.270 |
Why?
| Calcitonin | 3 | 2015 | 29 | 0.270 |
Why?
| Adenosine | 2 | 2018 | 211 | 0.260 |
Why?
| Female | 40 | 2024 | 61564 | 0.250 |
Why?
| Hospitals, Pediatric | 3 | 2019 | 505 | 0.230 |
Why?
| Length of Stay | 6 | 2018 | 1032 | 0.230 |
Why?
| Child | 22 | 2023 | 19129 | 0.230 |
Why?
| Meningitis, Pneumococcal | 1 | 2023 | 8 | 0.230 |
Why?
| Turner Syndrome | 1 | 2023 | 50 | 0.230 |
Why?
| Olfaction Disorders | 1 | 2023 | 47 | 0.230 |
Why?
| Humans | 52 | 2024 | 118972 | 0.220 |
Why?
| Postoperative Care | 2 | 2016 | 237 | 0.220 |
Why?
| Administration, Intravenous | 3 | 2020 | 136 | 0.220 |
Why?
| Child, Preschool | 15 | 2023 | 9491 | 0.210 |
Why?
| Male | 32 | 2023 | 57801 | 0.200 |
Why?
| Supine Position | 1 | 2021 | 39 | 0.190 |
Why?
| Infant, Very Low Birth Weight | 1 | 2021 | 68 | 0.190 |
Why?
| Prosthesis Fitting | 1 | 2020 | 14 | 0.190 |
Why?
| Osteogenesis Imperfecta | 1 | 2020 | 16 | 0.190 |
Why?
| Cosyntropin | 1 | 2020 | 5 | 0.190 |
Why?
| Post-Dural Puncture Headache | 1 | 2020 | 3 | 0.190 |
Why?
| Postnatal Care | 1 | 2020 | 68 | 0.180 |
Why?
| Sleep Apnea, Obstructive | 1 | 2023 | 231 | 0.180 |
Why?
| Adolescent | 18 | 2023 | 18480 | 0.180 |
Why?
| Catheter-Related Infections | 2 | 2019 | 60 | 0.180 |
Why?
| Glycine | 2 | 2022 | 162 | 0.180 |
Why?
| Prospective Studies | 11 | 2023 | 6471 | 0.170 |
Why?
| Sepsis | 2 | 2017 | 531 | 0.170 |
Why?
| Kidney Transplantation | 2 | 2017 | 585 | 0.170 |
Why?
| Coronary Care Units | 1 | 2018 | 14 | 0.170 |
Why?
| Fetofetal Transfusion | 1 | 2019 | 23 | 0.170 |
Why?
| Fetal Therapies | 1 | 2019 | 32 | 0.170 |
Why?
| Cross-Sectional Studies | 7 | 2023 | 4552 | 0.170 |
Why?
| Catheterization, Central Venous | 2 | 2019 | 95 | 0.170 |
Why?
| Interleukin-1 Receptor-Like 1 Protein | 1 | 2019 | 24 | 0.170 |
Why?
| Heart Defects, Congenital | 2 | 2018 | 703 | 0.170 |
Why?
| Corpus Callosum | 1 | 2019 | 57 | 0.170 |
Why?
| Sleep | 2 | 2021 | 660 | 0.170 |
Why?
| Pediatrics | 2 | 2017 | 985 | 0.170 |
Why?
| Video Recording | 1 | 2019 | 156 | 0.160 |
Why?
| Hypertrophy, Left Ventricular | 1 | 2019 | 107 | 0.160 |
Why?
| Aortic Coarctation | 1 | 2019 | 57 | 0.160 |
Why?
| Prenatal Care | 1 | 2020 | 252 | 0.160 |
Why?
| Endotoxemia | 1 | 2019 | 93 | 0.160 |
Why?
| 5'-Nucleotidase | 1 | 2018 | 34 | 0.160 |
Why?
| Endotoxins | 1 | 2019 | 234 | 0.160 |
Why?
| Laser Therapy | 1 | 2019 | 104 | 0.160 |
Why?
| Administration, Intranasal | 1 | 2017 | 79 | 0.150 |
Why?
| Orthopedic Procedures | 1 | 2020 | 225 | 0.150 |
Why?
| Counseling | 1 | 2020 | 353 | 0.150 |
Why?
| Graft Survival | 2 | 2017 | 504 | 0.150 |
Why?
| Endothelin-1 | 1 | 2019 | 168 | 0.150 |
Why?
| Isoantibodies | 1 | 2017 | 63 | 0.150 |
Why?
| Health Promotion | 1 | 2023 | 691 | 0.150 |
Why?
| Infant, Premature | 1 | 2021 | 480 | 0.150 |
Why?
| White Matter | 1 | 2019 | 115 | 0.150 |
Why?
| Fentanyl | 1 | 2017 | 70 | 0.150 |
Why?
| Labor, Obstetric | 2 | 2016 | 53 | 0.150 |
Why?
| Fetal Movement | 1 | 2016 | 7 | 0.150 |
Why?
| Hypernatremia | 1 | 2016 | 9 | 0.150 |
Why?
| Chromatography, High Pressure Liquid | 1 | 2018 | 490 | 0.150 |
Why?
| Fetal Monitoring | 1 | 2016 | 18 | 0.150 |
Why?
| Diazepam | 1 | 2016 | 23 | 0.150 |
Why?
| Angiomyolipoma | 1 | 2016 | 18 | 0.150 |
Why?
| Ventricular Remodeling | 1 | 2019 | 229 | 0.150 |
Why?
| Anti-Anxiety Agents | 1 | 2016 | 38 | 0.140 |
Why?
| Tacrolimus | 1 | 2017 | 151 | 0.140 |
Why?
| Biomarkers | 6 | 2019 | 3588 | 0.140 |
Why?
| Intensive Care Units, Neonatal | 1 | 2018 | 178 | 0.140 |
Why?
| Magnetic Resonance Imaging | 2 | 2019 | 3174 | 0.140 |
Why?
| Tuberous Sclerosis | 1 | 2016 | 38 | 0.140 |
Why?
| Hyponatremia | 1 | 2016 | 42 | 0.140 |
Why?
| Tandem Mass Spectrometry | 1 | 2018 | 421 | 0.140 |
Why?
| Adenosine Monophosphate | 1 | 2016 | 51 | 0.140 |
Why?
| Home Care Services | 1 | 2019 | 217 | 0.140 |
Why?
| Pre-Excitation Syndromes | 1 | 2015 | 5 | 0.140 |
Why?
| Wolff-Parkinson-White Syndrome | 1 | 2015 | 18 | 0.140 |
Why?
| Protein Precursors | 2 | 2013 | 126 | 0.130 |
Why?
| Ventricular Function, Left | 1 | 2019 | 468 | 0.130 |
Why?
| Adenovirus Infections, Human | 1 | 2015 | 14 | 0.130 |
Why?
| Cerebellum | 1 | 2017 | 203 | 0.130 |
Why?
| Tissue Donors | 1 | 2017 | 336 | 0.130 |
Why?
| Fractures, Bone | 1 | 2020 | 380 | 0.130 |
Why?
| Cytosine | 1 | 2015 | 46 | 0.130 |
Why?
| Polyomavirus Infections | 1 | 2015 | 22 | 0.130 |
Why?
| Healthcare Disparities | 1 | 2020 | 496 | 0.130 |
Why?
| Cardiotonic Agents | 2 | 2012 | 127 | 0.130 |
Why?
| Shock, Traumatic | 1 | 2014 | 18 | 0.130 |
Why?
| Bacteremia | 1 | 2016 | 161 | 0.130 |
Why?
| Health Resources | 1 | 2016 | 132 | 0.130 |
Why?
| Enterovirus D, Human | 1 | 2016 | 76 | 0.120 |
Why?
| Learning | 2 | 2017 | 374 | 0.120 |
Why?
| Rectum | 1 | 2015 | 157 | 0.120 |
Why?
| Appendicitis | 1 | 2016 | 125 | 0.120 |
Why?
| Organophosphonates | 1 | 2015 | 94 | 0.120 |
Why?
| C-Reactive Protein | 2 | 2013 | 360 | 0.120 |
Why?
| Pediatric Nurse Practitioners | 1 | 2014 | 6 | 0.120 |
Why?
| Mucocutaneous Lymph Node Syndrome | 1 | 2015 | 77 | 0.120 |
Why?
| Cross Infection | 1 | 2016 | 205 | 0.120 |
Why?
| Patient Education as Topic | 1 | 2019 | 699 | 0.120 |
Why?
| Immunoglobulins, Intravenous | 1 | 2015 | 128 | 0.120 |
Why?
| Hirschsprung Disease | 1 | 2015 | 89 | 0.120 |
Why?
| Graft Rejection | 1 | 2017 | 555 | 0.120 |
Why?
| Hospital Mortality | 4 | 2022 | 814 | 0.120 |
Why?
| Prognosis | 6 | 2017 | 3443 | 0.120 |
Why?
| Dibenzothiazepines | 1 | 2013 | 20 | 0.120 |
Why?
| Metabolomics | 1 | 2018 | 550 | 0.120 |
Why?
| Herpesviridae Infections | 1 | 2015 | 142 | 0.120 |
Why?
| Mutation, Missense | 1 | 2015 | 300 | 0.120 |
Why?
| Gastroenterology | 1 | 2015 | 158 | 0.120 |
Why?
| Severity of Illness Index | 3 | 2017 | 2674 | 0.120 |
Why?
| Cardiovascular Surgical Procedures | 1 | 2013 | 37 | 0.110 |
Why?
| Enterovirus Infections | 1 | 2016 | 164 | 0.110 |
Why?
| Conditioning, Classical | 1 | 2014 | 89 | 0.110 |
Why?
| Pregnancy | 6 | 2024 | 5690 | 0.110 |
Why?
| Magnesium | 1 | 2013 | 150 | 0.110 |
Why?
| Nerve Tissue Proteins | 1 | 2017 | 551 | 0.110 |
Why?
| Histocompatibility Testing | 1 | 2013 | 123 | 0.110 |
Why?
| Disease Outbreaks | 1 | 2016 | 322 | 0.110 |
Why?
| Critical Care | 1 | 2017 | 492 | 0.110 |
Why?
| Cytomegalovirus Infections | 1 | 2015 | 187 | 0.110 |
Why?
| Headache | 1 | 2013 | 128 | 0.110 |
Why?
| Quality of Health Care | 1 | 2017 | 586 | 0.110 |
Why?
| Feces | 1 | 2015 | 396 | 0.110 |
Why?
| Fluid Therapy | 1 | 2013 | 130 | 0.110 |
Why?
| Hospital Medicine | 1 | 2014 | 84 | 0.110 |
Why?
| Kidney Neoplasms | 1 | 2016 | 334 | 0.110 |
Why?
| Electrocardiography | 1 | 2015 | 556 | 0.110 |
Why?
| Analgesics, Non-Narcotic | 1 | 2013 | 116 | 0.110 |
Why?
| HLA-DR Antigens | 1 | 2013 | 224 | 0.110 |
Why?
| Triage | 1 | 2014 | 203 | 0.110 |
Why?
| Seizures | 1 | 2015 | 345 | 0.110 |
Why?
| Proteomics | 2 | 2015 | 876 | 0.110 |
Why?
| Cardiovascular Diseases | 1 | 2024 | 1798 | 0.100 |
Why?
| Kidney Failure, Chronic | 1 | 2017 | 516 | 0.100 |
Why?
| Cardiac Output, Low | 1 | 2012 | 68 | 0.100 |
Why?
| Trauma Centers | 1 | 2014 | 388 | 0.100 |
Why?
| Thoracic Surgical Procedures | 1 | 2012 | 64 | 0.100 |
Why?
| Gene Expression | 1 | 2017 | 1489 | 0.100 |
Why?
| Antipsychotic Agents | 1 | 2013 | 193 | 0.100 |
Why?
| Proteome | 1 | 2015 | 353 | 0.100 |
Why?
| Wounds, Nonpenetrating | 1 | 2014 | 285 | 0.100 |
Why?
| Fear | 1 | 2014 | 307 | 0.100 |
Why?
| Parents | 1 | 2019 | 1212 | 0.100 |
Why?
| Cerebral Cortex | 1 | 2014 | 416 | 0.090 |
Why?
| Obesity | 1 | 2023 | 2746 | 0.090 |
Why?
| Adult | 9 | 2024 | 31512 | 0.090 |
Why?
| Leukemia, Myeloid, Acute | 1 | 2016 | 532 | 0.090 |
Why?
| Intestinal Mucosa | 1 | 2015 | 531 | 0.090 |
Why?
| Vasodilator Agents | 1 | 2012 | 328 | 0.090 |
Why?
| Brain Injuries | 1 | 2015 | 484 | 0.090 |
Why?
| Intensive Care Units, Pediatric | 3 | 2017 | 157 | 0.090 |
Why?
| Prevalence | 3 | 2023 | 2326 | 0.090 |
Why?
| Neoplasm Proteins | 1 | 2013 | 401 | 0.090 |
Why?
| Medicaid | 1 | 2013 | 411 | 0.090 |
Why?
| Hippocampus | 1 | 2014 | 735 | 0.090 |
Why?
| Respiration, Artificial | 3 | 2018 | 545 | 0.090 |
Why?
| Time Factors | 5 | 2019 | 6412 | 0.080 |
Why?
| Kinetics | 3 | 2018 | 1624 | 0.080 |
Why?
| Birth Weight | 2 | 2022 | 465 | 0.080 |
Why?
| Gastrointestinal Microbiome | 1 | 2015 | 548 | 0.080 |
Why?
| Demography | 1 | 2008 | 274 | 0.080 |
Why?
| Nicotine | 1 | 2010 | 276 | 0.080 |
Why?
| Treatment Outcome | 6 | 2019 | 9342 | 0.080 |
Why?
| Infant Care | 1 | 2007 | 43 | 0.080 |
Why?
| Risk Factors | 5 | 2019 | 9000 | 0.080 |
Why?
| Community Health Nursing | 1 | 2007 | 63 | 0.070 |
Why?
| Case-Control Studies | 3 | 2023 | 3171 | 0.070 |
Why?
| Aging | 1 | 2017 | 1670 | 0.070 |
Why?
| Respiratory Sounds | 1 | 2007 | 119 | 0.070 |
Why?
| Predictive Value of Tests | 3 | 2018 | 1868 | 0.070 |
Why?
| Anti-Bacterial Agents | 1 | 2016 | 1510 | 0.070 |
Why?
| Gene Expression Profiling | 1 | 2013 | 1597 | 0.070 |
Why?
| United States | 5 | 2021 | 12555 | 0.070 |
Why?
| Gestational Age | 2 | 2021 | 765 | 0.070 |
Why?
| Cystic Fibrosis | 1 | 2015 | 964 | 0.070 |
Why?
| Environment | 1 | 2007 | 346 | 0.070 |
Why?
| Incidence | 3 | 2016 | 2424 | 0.070 |
Why?
| Colorado | 4 | 2016 | 4196 | 0.070 |
Why?
| Cohort Studies | 4 | 2017 | 5116 | 0.070 |
Why?
| Neoplasms | 1 | 2019 | 2179 | 0.060 |
Why?
| Self Efficacy | 1 | 2008 | 366 | 0.060 |
Why?
| Memantine | 2 | 2015 | 18 | 0.060 |
Why?
| Mothers | 2 | 2021 | 682 | 0.060 |
Why?
| Injections, Intravenous | 2 | 2016 | 210 | 0.060 |
Why?
| Tobacco Smoke Pollution | 1 | 2007 | 233 | 0.060 |
Why?
| Poverty | 1 | 2007 | 444 | 0.060 |
Why?
| Healthy Lifestyle | 1 | 2023 | 33 | 0.060 |
Why?
| Combined Modality Therapy | 2 | 2017 | 1166 | 0.060 |
Why?
| Calcitonin Gene-Related Peptide | 2 | 2013 | 33 | 0.060 |
Why?
| Vaccines, Conjugate | 1 | 2023 | 63 | 0.060 |
Why?
| Odorants | 1 | 2023 | 137 | 0.060 |
Why?
| Smell | 1 | 2023 | 118 | 0.060 |
Why?
| Administration, Oral | 2 | 2016 | 756 | 0.050 |
Why?
| Receptors, N-Methyl-D-Aspartate | 2 | 2015 | 191 | 0.050 |
Why?
| Threonine | 1 | 2022 | 45 | 0.050 |
Why?
| Survival Rate | 2 | 2017 | 1720 | 0.050 |
Why?
| Streptococcus pneumoniae | 1 | 2023 | 141 | 0.050 |
Why?
| Analysis of Variance | 2 | 2016 | 1293 | 0.050 |
Why?
| Inflammation | 1 | 2012 | 2566 | 0.050 |
Why?
| Pneumococcal Vaccines | 1 | 2023 | 140 | 0.050 |
Why?
| Serine | 1 | 2022 | 138 | 0.050 |
Why?
| Intensive Care Units | 2 | 2016 | 635 | 0.050 |
Why?
| Hearing | 1 | 2023 | 135 | 0.050 |
Why?
| Life Style | 1 | 2024 | 430 | 0.050 |
Why?
| Disease Models, Animal | 3 | 2017 | 3730 | 0.050 |
Why?
| Marital Status | 1 | 2021 | 43 | 0.050 |
Why?
| Brain | 1 | 2013 | 2490 | 0.050 |
Why?
| Mice, Inbred C57BL | 3 | 2017 | 4908 | 0.050 |
Why?
| Epiphyses | 1 | 2020 | 20 | 0.050 |
Why?
| Maternal Age | 1 | 2021 | 122 | 0.050 |
Why?
| Signal Transduction | 1 | 2014 | 4709 | 0.050 |
Why?
| Blood Patch, Epidural | 1 | 2020 | 5 | 0.050 |
Why?
| Spinal Puncture | 1 | 2020 | 16 | 0.050 |
Why?
| Equipment Failure Analysis | 1 | 2020 | 139 | 0.050 |
Why?
| Family | 1 | 2023 | 585 | 0.040 |
Why?
| Patient Readmission | 2 | 2016 | 634 | 0.040 |
Why?
| Fetoscopy | 1 | 2019 | 29 | 0.040 |
Why?
| Animals | 6 | 2017 | 33381 | 0.040 |
Why?
| Weight Loss | 1 | 2024 | 655 | 0.040 |
Why?
| Time | 1 | 2019 | 77 | 0.040 |
Why?
| Central Venous Catheters | 1 | 2019 | 42 | 0.040 |
Why?
| Asthma | 2 | 2014 | 2158 | 0.040 |
Why?
| Middle Aged | 4 | 2017 | 27617 | 0.040 |
Why?
| Educational Status | 1 | 2021 | 437 | 0.040 |
Why?
| Spectrum Analysis | 1 | 2019 | 88 | 0.040 |
Why?
| Tertiary Care Centers | 1 | 2019 | 119 | 0.040 |
Why?
| Logistic Models | 2 | 2015 | 1901 | 0.040 |
Why?
| Amino Acids | 1 | 2022 | 464 | 0.040 |
Why?
| Task Performance and Analysis | 1 | 2019 | 164 | 0.040 |
Why?
| Randomized Controlled Trials as Topic | 1 | 2023 | 1244 | 0.040 |
Why?
| Rewarming | 1 | 2018 | 17 | 0.040 |
Why?
| Follow-Up Studies | 2 | 2017 | 4596 | 0.040 |
Why?
| GPI-Linked Proteins | 1 | 2018 | 56 | 0.040 |
Why?
| Population Surveillance | 1 | 2021 | 413 | 0.040 |
Why?
| Radiography | 1 | 2020 | 861 | 0.040 |
Why?
| Basal Forebrain | 1 | 2017 | 3 | 0.040 |
Why?
| Chromosomes, Human, Pair 21 | 1 | 2017 | 33 | 0.040 |
Why?
| Cholinergic Neurons | 1 | 2017 | 17 | 0.040 |
Why?
| Kidney Function Tests | 1 | 2017 | 164 | 0.040 |
Why?
| Vasoconstrictor Agents | 1 | 2017 | 122 | 0.040 |
Why?
| Mice, Inbred C3H | 1 | 2017 | 250 | 0.040 |
Why?
| Surveys and Questionnaires | 1 | 2008 | 4708 | 0.040 |
Why?
| Pediatric Obesity | 1 | 2023 | 524 | 0.040 |
Why?
| Diuretics | 1 | 2016 | 76 | 0.040 |
Why?
| HLA Antigens | 1 | 2017 | 230 | 0.040 |
Why?
| Oximetry | 1 | 2016 | 84 | 0.040 |
Why?
| Patient Safety | 1 | 2019 | 281 | 0.030 |
Why?
| Extracellular Space | 1 | 2016 | 127 | 0.030 |
Why?
| Accessory Atrioventricular Bundle | 1 | 2015 | 11 | 0.030 |
Why?
| Solubility | 1 | 2016 | 235 | 0.030 |
Why?
| Appendectomy | 1 | 2016 | 73 | 0.030 |
Why?
| Sodium | 1 | 2016 | 200 | 0.030 |
Why?
| Pandemics | 1 | 2024 | 1355 | 0.030 |
Why?
| Memory | 1 | 2017 | 230 | 0.030 |
Why?
| Capsule Endoscopes | 1 | 2015 | 8 | 0.030 |
Why?
| Postoperative Period | 1 | 2016 | 309 | 0.030 |
Why?
| Causality | 1 | 2015 | 109 | 0.030 |
Why?
| COS Cells | 1 | 2015 | 184 | 0.030 |
Why?
| BK Virus | 1 | 2015 | 15 | 0.030 |
Why?
| Leukocyte L1 Antigen Complex | 1 | 2015 | 32 | 0.030 |
Why?
| Epilepsies, Partial | 1 | 2015 | 28 | 0.030 |
Why?
| Chi-Square Distribution | 1 | 2016 | 525 | 0.030 |
Why?
| Constipation | 1 | 2015 | 76 | 0.030 |
Why?
| Permeability | 1 | 2015 | 156 | 0.030 |
Why?
| Age Distribution | 1 | 2015 | 362 | 0.030 |
Why?
| Sex Distribution | 1 | 2015 | 351 | 0.030 |
Why?
| Pain Management | 1 | 2017 | 294 | 0.030 |
Why?
| Protein Structure, Secondary | 1 | 2015 | 338 | 0.030 |
Why?
| Viremia | 1 | 2015 | 132 | 0.030 |
Why?
| Glomerular Filtration Rate | 1 | 2017 | 683 | 0.030 |
Why?
| Protein Subunits | 1 | 2015 | 211 | 0.030 |
Why?
| Quetiapine Fumarate | 1 | 2013 | 25 | 0.030 |
Why?
| Bronchitis | 1 | 2014 | 39 | 0.030 |
Why?
| Young Adult | 3 | 2016 | 10793 | 0.030 |
Why?
| Heart Arrest | 1 | 2017 | 291 | 0.030 |
Why?
| Multivariate Analysis | 1 | 2018 | 1474 | 0.030 |
Why?
| Oregon | 1 | 2013 | 69 | 0.030 |
Why?
| Insurance Claim Review | 1 | 2014 | 67 | 0.030 |
Why?
| Candy | 1 | 2013 | 5 | 0.030 |
Why?
| Protein Array Analysis | 1 | 2014 | 63 | 0.030 |
Why?
| Oxytocics | 1 | 2013 | 14 | 0.030 |
Why?
| Isotonic Solutions | 1 | 2013 | 43 | 0.030 |
Why?
| Ice | 1 | 2013 | 22 | 0.030 |
Why?
| Cattle | 1 | 2016 | 978 | 0.030 |
Why?
| Immunosuppressive Agents | 1 | 2017 | 681 | 0.030 |
Why?
| Cytosol | 1 | 2014 | 221 | 0.030 |
Why?
| T-Lymphoma Invasion and Metastasis-inducing Protein 1 | 1 | 2013 | 4 | 0.030 |
Why?
| S100 Calcium Binding Protein beta Subunit | 1 | 2013 | 9 | 0.030 |
Why?
| Parity | 1 | 2013 | 101 | 0.030 |
Why?
| Costs and Cost Analysis | 1 | 2014 | 202 | 0.030 |
Why?
| Regulatory-Associated Protein of mTOR | 1 | 2013 | 19 | 0.030 |
Why?
| Mice | 3 | 2015 | 15520 | 0.030 |
Why?
| Liver Function Tests | 1 | 2013 | 107 | 0.030 |
Why?
| Heart Diseases | 1 | 2016 | 341 | 0.030 |
Why?
| Oxytocin | 1 | 2013 | 44 | 0.030 |
Why?
| S100 Proteins | 1 | 2013 | 35 | 0.030 |
Why?
| Electroencephalography | 1 | 2015 | 387 | 0.030 |
Why?
| Liver Cirrhosis | 1 | 2015 | 245 | 0.030 |
Why?
| Monitoring, Physiologic | 1 | 2015 | 271 | 0.030 |
Why?
| Placenta | 1 | 2019 | 638 | 0.030 |
Why?
| Nerve Growth Factors | 1 | 2013 | 74 | 0.030 |
Why?
| Caregivers | 1 | 2019 | 709 | 0.030 |
Why?
| Quality of Life | 1 | 2023 | 2366 | 0.030 |
Why?
| Guanine Nucleotide Exchange Factors | 1 | 2013 | 59 | 0.030 |
Why?
| Migraine Disorders | 1 | 2013 | 79 | 0.030 |
Why?
| Intubation | 1 | 2012 | 5 | 0.030 |
Why?
| Recurrence | 1 | 2015 | 975 | 0.030 |
Why?
| Statistics, Nonparametric | 1 | 2013 | 403 | 0.030 |
Why?
| Injury Severity Score | 1 | 2014 | 528 | 0.030 |
Why?
| Cesarean Section | 1 | 2013 | 165 | 0.030 |
Why?
| Biopsy | 1 | 2015 | 1079 | 0.030 |
Why?
| Pain | 1 | 2017 | 735 | 0.030 |
Why?
| Calcium-Binding Proteins | 1 | 2013 | 217 | 0.030 |
Why?
| Age Factors | 1 | 2018 | 2995 | 0.020 |
Why?
| Waiting Lists | 1 | 2013 | 228 | 0.020 |
Why?
| Critical Illness | 1 | 2016 | 662 | 0.020 |
Why?
| Genotype | 1 | 2016 | 1882 | 0.020 |
Why?
| Reoperation | 1 | 2013 | 557 | 0.020 |
Why?
| Sensitivity and Specificity | 1 | 2015 | 1795 | 0.020 |
Why?
| Phenotype | 1 | 2019 | 3003 | 0.020 |
Why?
| Linear Models | 1 | 2013 | 827 | 0.020 |
Why?
| Cell Nucleus | 1 | 2014 | 580 | 0.020 |
Why?
| Heart Rate | 1 | 2014 | 729 | 0.020 |
Why?
| ROC Curve | 1 | 2012 | 473 | 0.020 |
Why?
| Comorbidity | 1 | 2015 | 1527 | 0.020 |
Why?
| Intubation, Intratracheal | 1 | 2012 | 226 | 0.020 |
Why?
| Pilot Projects | 1 | 2015 | 1419 | 0.020 |
Why?
| Water | 1 | 2013 | 425 | 0.020 |
Why?
| Anxiety | 1 | 2016 | 845 | 0.020 |
Why?
| TOR Serine-Threonine Kinases | 1 | 2013 | 368 | 0.020 |
Why?
| Bacteria | 1 | 2016 | 757 | 0.020 |
Why?
| Analgesics, Opioid | 1 | 2017 | 794 | 0.020 |
Why?
| Adaptor Proteins, Signal Transducing | 1 | 2013 | 394 | 0.020 |
Why?
| Child Abuse | 1 | 2015 | 466 | 0.020 |
Why?
| Patient Discharge | 1 | 2016 | 796 | 0.020 |
Why?
| Hematopoietic Stem Cell Transplantation | 1 | 2015 | 540 | 0.020 |
Why?
| Chronic Disease | 1 | 2015 | 1636 | 0.020 |
Why?
| Risk Assessment | 1 | 2018 | 3057 | 0.020 |
Why?
| Antiviral Agents | 1 | 2015 | 654 | 0.020 |
Why?
| Dose-Response Relationship, Drug | 1 | 2013 | 1945 | 0.020 |
Why?
| Kidney | 1 | 2016 | 1353 | 0.020 |
Why?
| Coronary Artery Disease | 1 | 2015 | 647 | 0.020 |
Why?
| Phosphorylation | 1 | 2013 | 1633 | 0.020 |
Why?
| Pneumonia | 1 | 2014 | 592 | 0.020 |
Why?
| Alzheimer Disease | 1 | 2014 | 513 | 0.020 |
Why?
| Glucose | 1 | 2013 | 953 | 0.020 |
Why?
| Antineoplastic Agents | 1 | 2019 | 1974 | 0.020 |
Why?
| Reproducibility of Results | 1 | 2015 | 2874 | 0.020 |
Why?
| Acute Kidney Injury | 1 | 2015 | 709 | 0.020 |
Why?
| Blood Pressure | 1 | 2014 | 1664 | 0.020 |
Why?
| Sickness Impact Profile | 1 | 2007 | 51 | 0.020 |
Why?
| Vulnerable Populations | 1 | 2007 | 147 | 0.020 |
Why?
| Mental Disorders | 1 | 2013 | 939 | 0.020 |
Why?
| Gene Expression Regulation | 1 | 2013 | 2445 | 0.010 |
Why?
| Socioeconomic Factors | 1 | 2007 | 1129 | 0.010 |
Why?
| Program Evaluation | 1 | 2007 | 845 | 0.010 |
Why?
| Emergency Service, Hospital | 1 | 2013 | 1864 | 0.010 |
Why?
| Aged | 1 | 2010 | 19657 | 0.010 |
Why?
|
|
Tong's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|